April 18, 2017
2 min read
Save

Longer duration of levofloxacin may lead to higher minimum inhibitory concentrations

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients undergoing a longer duration of levofloxacin 1.5% administration after cataract surgery experienced higher minimum inhibitory concentrations of levofloxacin against Staphylococcus epidermidis, according to a study.

Researchers randomized 103 patients who underwent cataract surgery to two groups: those who received 1 week of levofloxacin 1.5% ophthalmic solution and those who received 1 month duration of the drug. Each patient’s conjunctival sac was scraped for bacteria before administration of the solution, 1-week postoperatively, at the completion of administration, and again at 1, 3 and 6 months after administration completion.

Researchers examined the levels of culture growth and minimum inhibitory concentration (MIC) of levofloxacin against recovered strains of S. epidermidis and found that, at the 3-month time point, the MIC of patients in the 1-month postoperative group was about twice that of patients in the 1-week postoperative group.

“[L]onger administration of levofloxacin in the 1-month postoperative group might suppress the growth of levofloxacin-susceptible strains compared with shorter administration in the 1-week postoperative group. Furthermore, we believe this enhanced contact increased the proportion of resistant bacterial strains among the bacterial flora in the 1-month postoperative group, leading to higher MIC levels at completion of administration than levels in the 1-week postoperative group with a decline in susceptibility,” the authors wrote. – by Robert Linnehan

Disclosures: Nejima reports receiving grant funding from Santen and lectures fees from Santen and Senju. Please see the full study for a list of all other authors’ relevant financial disclosures.